ARTICLE | Distillery Therapeutics
Inhibiting YTHDF2 to treat AML
May 14, 2019 2:21 PM UTC
INDICATION: Acute myelogenous leukemia (AML)...
BCIQ Company Profiles
BCIQ Target Profiles
INDICATION: Acute myelogenous leukemia (AML)...
BCIQ Company Profiles
BCIQ Target Profiles
BCIQ Company Profiles
BCIQ Target Profiles